The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia, Archives of Disease in Childhood, vol.8, issue.Suppl 1, pp.613-620, 2013. ,
DOI : 10.1136/archdischild-2012-303333
Pulmonary hypertension in bronchopulmonary dysplasia: Clinical findings, cardiovascular anomalies and outcomes, Pediatric Pulmonology, vol.306, issue.1, pp.49-59, 2014. ,
DOI : 10.1002/ppul.22797
Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of pulmonary hypertension, International Society of Heart and Lung Transplantation (ISHLT), pp.1219-63, 2009. ,
Pulmonary hypertension in bronchopulmonary dysplasia, Progress in Pediatric Cardiology, vol.27, issue.1-2 ,
DOI : 10.1016/j.ppedcard.2009.09.007
Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: A systematic review, Respiratory Medicine, vol.108, issue.3, 2014. ,
DOI : 10.1016/j.rmed.2014.01.003
Advances in the management of pediatric pulmonary hypertension. Respir Care, pp.1314-1353, 2011. ,
Pulmonary arterial hypertension in children, European Respiratory Journal, vol.21, issue.1, 2003. ,
DOI : 10.1183/09031936.03.00088302
Pulmonary hypertension in pediatric and neonatal intensive care unit. Part I: Physiopathology. Arch Pediatr, pp.68-75, 2011. ,
Cellular and molecular pathobiology of pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.43, issue.12, 2004. ,
DOI : 10.1016/j.jacc.2004.02.029
In Vivo Evidence for a Myogenic Response in the Fetal Pulmonary Circulation, Pediatric Research, vol.268, issue.3, pp.425-456, 1999. ,
DOI : 10.1203/00006450-199903000-00022
Pulmonary hypertension in bronchopulmonary dysplasia, Seminars in Perinatology, vol.37, issue.2, pp.124-155 ,
DOI : 10.1053/j.semperi.2013.01.009
Echocardiographic Indexes for the Non-Invasive Evaluation of Pulmonary Hemodynamics, Journal of the American Society of Echocardiography, vol.23, issue.3, pp.225-264, 2010. ,
DOI : 10.1016/j.echo.2010.01.003
Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia, Pediatric Pulmonology, vol.116, issue.11, pp.1042-53, 2012. ,
DOI : 10.1002/ppul.22609
Pulmonary hypertension in infants with bronchopulmonary dysplasia, Korean Journal of Pediatrics, vol.53, issue.6, pp.688-93, 2010. ,
DOI : 10.3345/kjp.2010.53.6.688
Pulmonary hypertension in pediatric and neonatal intensive care unit. Part II: diagnosis and treatment. Arch Pediatr, Feb, vol.18, issue.2, pp.195-203, 2011. ,
BOOST II United Kingdom Collaborative Group, BOOST II Australia Collaborative Group, BOOST II New Zealand Collaborative Group, Oxygen saturation and outcomes in preterm infants, N Engl J Med, vol.368, issue.22, pp.2094-104, 2013. ,
Bronchopulmonary dysplasia-associated pulmonary arterial hypertension of very preterm infants. Arch Pediatr, pp.44-53, 2013. ,
Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1461, 2004. ,
DOI : 10.1056/NEJMra040291
URL : https://hal.archives-ouvertes.fr/hal-01455600
Inhaled Nitric Oxide as a Cause of Selective Pulmonary Vasodilatation in Pulmonary Hypertension, Survey of Anesthesiology, vol.36, issue.6, pp.1173-1177, 1991. ,
DOI : 10.1097/00132586-199212000-00001
Nitric oxide during hand ventilation in patient with acute respiratory failure, The Lancet, vol.340, issue.8826, pp.1038-1047, 1992. ,
DOI : 10.1016/0140-6736(92)93052-O
Nitric oxide inhalation in infants with respiratory distress syndrome, The Journal of Pediatrics, vol.130, issue.2, pp.225-255, 1997. ,
DOI : 10.1016/S0022-3476(97)70347-0
Changes in Oxygenation With Inhaled Nitric Oxide in Severe Bronchopulmonary Dysplasia, PEDIATRICS, vol.103, issue.3, pp.610-618, 1999. ,
DOI : 10.1542/peds.103.3.610
Sildenafil for the Treatment of Pulmonary Hypertension in Pediatric Patients, Pediatric Cardiology, vol.42, issue.851, pp.871-82, 2009. ,
DOI : 10.1007/s00246-009-9523-1
Safety of sildenafil in infants. Pediatr Crit Care Med, pp.362-370, 2014. ,
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction, Int J Impot Res, vol.8, issue.2, pp.47-52, 1996. ,
Sildenafil Ameliorates Effects of Inhaled Nitric Oxide Withdrawal, Anesthesiology, vol.91, issue.1 ,
DOI : 10.1097/00000542-199907000-00041
Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension, Heart, vol.84, issue.2, p.4, 2000. ,
DOI : 10.1136/heart.84.2.e4
Sildenafil in Primary Pulmonary Hypertension, New England Journal of Medicine, vol.343, issue.18, p.1342, 2000. ,
DOI : 10.1056/NEJM200011023431814
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.353, issue.20, pp.2148-57, 2005. ,
DOI : 10.1056/NEJMoa050010
Is sildenafil effective for treating pulmonary hypertension after pediatric heart surgery? Interact Cardiovasc Thorac Surg, Feb, vol.5, issue.1, pp.52-56, 2006. ,
Therapeutic Applications of Sildenafil Citrate in the Management of Paediatric Pulmonary Hypertension, Drugs, vol.89, issue.1, pp.57-73, 2007. ,
DOI : 10.2165/00003495-200767010-00005
Paediatric pulmonary hypertension and sildenafil: current practice and controversies. Arch Dis Child Educ Pract Ed, pp.141-148, 2013. ,
Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.6, pp.572-577, 2013. ,
DOI : 10.1164/rccm.201210-1928PP
Ocular findings of oral sildenafil use in term and near-term neonates, Journal of American Association for Pediatric Ophthalmology and Strabismus, vol.14, issue.2, pp.159-62, 2010. ,
DOI : 10.1016/j.jaapos.2009.12.161
Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use, European Journal of Pediatrics, vol.85, issue.8, 2011. ,
DOI : 10.1007/s00431-011-1422-9
Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.165, issue.8, pp.1098-102, 2002. ,
DOI : 10.1164/ajrccm.165.8.2107097
Sildenafil for pulmonary hypertension treatment after cardiac surgery, Jornal de Pediatria, vol.81, issue.2, pp.175-183, 2005. ,
DOI : 10.2223/1325
Oral Sildenafil for Treatment of Severe Pulmonary Hypertension in an Infant, Neonatology, vol.88, issue.2, pp.109-121, 2005. ,
DOI : 10.1159/000085646
Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.95, issue.2, pp.109-123, 2010. ,
DOI : 10.1136/adc.2009.168336
Diagnosis and treatment of pulmonary hypertension in infancy. Early Hum Dev, pp.865-74, 2013. ,
Sildenafil Prevents Rebound Pulmonary Hypertension after Withdrawal of Nitric Oxide in Children, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.9, pp.1042-1049, 2006. ,
DOI : 10.1164/rccm.200605-694OC
The effect of sildenafil on evolving bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled pilot study, The Journal of Maternal-Fetal & Neonatal Medicine, vol.125, issue.5 ,
DOI : 10.1164/ajrccm.163.7.2011060
Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, pp.407-420, 2013. ,
Effects of Long-Term Sildenafil Treatment for Pulmonary Hypertension in Infants with Chronic Lung Disease, The Journal of Pediatrics, vol.154, issue.3, pp.379-84, 2009. ,
DOI : 10.1016/j.jpeds.2008.09.021
Dysplasie bronchopulmonaire du nouveau-n?? pr??matur????: d???hier ?? aujourd???hui, Revue de Pneumologie Clinique, vol.69, issue.4, pp.207-223 ,
DOI : 10.1016/j.pneumo.2013.05.003
Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia, N Engl J Med Feb, vol.16276, issue.7, pp.357-68, 1967. ,
Definitions and Diagnostic Criteria for Bronchopulmonary Dysplasia, Seminars in Perinatology, vol.30, issue.4 ,
DOI : 10.1053/j.semperi.2006.05.002
Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know, Pediatric Radiology, vol.101, issue.S1, pp.92-100 ,
DOI : 10.1007/s00247-011-2255-4
Bronchopulmonary dysplasia. Lancet, Apr, vol.29367, issue.9520, pp.1421-1452, 2006. ,
Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol, pp.219-245, 2006. ,
Pathology of new bronchopulmonary dysplasia, Seminars in Neonatology, vol.8, issue.1, 2003. ,
DOI : 10.1016/S1084-2756(02)00193-8
Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia, PEDIATRICS, vol.116, issue.6, 2005. ,
DOI : 10.1542/peds.2005-0249
Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants, Early Human Development, vol.54, issue.3, 1999. ,
DOI : 10.1016/S0378-3782(98)00101-7
Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants, Paediatric Respiratory Reviews, vol.5, pp.241-245, 2004. ,
DOI : 10.1016/S1526-0542(04)90045-0
Site-specific characteristics of infants developing bronchopulmonary dysplasia, Journal of Perinatology, vol.26, issue.8, pp.428-463, 2006. ,
DOI : 10.1038/sj.jp.7211567
Association between Fluid Intake and Weight Loss during the First Ten Days of Life and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants, The Journal of Pediatrics, vol.147, issue.6, pp.786-90, 2005. ,
DOI : 10.1016/j.jpeds.2005.06.039
The Genetics of Bronchopulmonary Dysplasia, Seminars in Perinatology, vol.30, issue.4, 2006. ,
DOI : 10.1053/j.semperi.2006.05.005
Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease Respiratory Outcomes of the Surfactant Positive Pressure and Oximetry Randomized Trial (SUPPORT) The chest radiograph appearances of very premature infants at 36 weeks post-conceptional age, J Pediatr. J Pediatr. Br J Radiol, vol.126165, issue.42, pp.605-615, 1995. ,
High-Resolution CT of the Chest in Children and Young Adults Who Were Born Prematurely: Findings in a Population-Based Study, American Journal of Roentgenology, vol.187, issue.4, pp.1012-1020, 2006. ,
DOI : 10.2214/AJR.05.0383
Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants, The Journal of Pediatrics, vol.108, issue.2, 1986. ,
DOI : 10.1016/S0022-3476(86)81006-X
Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial, The Journal of Pediatrics, vol.106, issue.6, pp.963-972, 1985. ,
DOI : 10.1016/S0022-3476(85)80253-5
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth):CD004454. 72. Suresh GK, Soll RF. Overview of surfactant replacement trials, Cochrane Database Syst Rev. J Perinatol, vol.25, issue.3 2, pp.40-44, 2005. ,
Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome, CD003063. 75. Richmond S, Wyllie J. European Resuscitation Council Guidelines for Resuscitation, 2007. ,
Eliminating sleepassociated hypoxemia improves growth in infants with bronchopulmonary dysplasia, Pediatrics, 1996. ,
Effects of Inhaled Nitric Oxide on Pulmonary Edema and Lung Neutrophil Accumulation in Severe Experimental Hyaline Membrane Disease, Pediatric Research, vol.37, issue.4, pp.457-63, 1997. ,
DOI : 10.1203/00006450-199704000-00002
Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm neonates, Seminars in Fetal and Neonatal Medicine, vol.14, issue.1, pp.28-34, 2009. ,
DOI : 10.1016/j.siny.2008.08.009
Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial, The Lancet, vol.376, issue.9738, pp.346-54, 2010. ,
DOI : 10.1016/S0140-6736(10)60664-2
Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension, Journal of Perinatology, vol.27, issue.7, pp.543-550 ,
DOI : 10.1111/j.1748-720X.2011.00588.x
Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia, Journal of Perinatology, vol.33, issue.7, 2013. ,
DOI : 10.1542/peds.2007-1583
Respir Care, pp.1252-62, 2009. ,
Early optimal nutrition improves neurodevelopmental outcomes for very preterm infants, Nutrition Reviews, vol.72, issue.8, pp.532-572, 2014. ,
DOI : 10.1111/nure.12110
Association des Utilisateurs de Dossiers Informatisés en Pédiatrie, Obstétrique et Gynécologie Available from, 2013. ,
Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia, Dan Med J. Korean Circ J, vol.6040, issue.863, pp.4688131-4688137, 2010. ,
Pulmonary hypertension in chronic neonatal lung disease, Paediatric Respiratory Reviews, vol.11, issue.3 ,
DOI : 10.1016/j.prrv.2010.05.001
Colonisation par Ureaplasma urealyticum et maladie pulmonaire chronique chez les nouveau-nés prématurés de moins de 32 semaines de gestation. Arch Pédiatrie, pp.39-46, 2001. ,
Ureaplasma urealyticum, Mycoplasma hominis et pathologiesn??onatales : Donn??es personnelles et revue de la litt??rature, Archives de P??diatrie, vol.12, pp.12-20, 2005. ,
DOI : 10.1016/S0929-693X(05)80004-1
Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics, pp.682-691, 2012. ,
Pulmonary Vasodilator Therapy in the NICU: Inhaled Nitric Oxide, Sildenafil, and Other Pulmonary Vasodilating Agents, Clinics in Perinatology, vol.39, issue.1, pp.149-64, 2012. ,
DOI : 10.1016/j.clp.2011.12.006
Use of Inhaled Nitric Oxide in Preterm Infants, PEDIATRICS, vol.133, issue.1, pp.164-70, 2014. ,
DOI : 10.1542/peds.2013-3444
Pulmonary Vascular Effects of Inhaled Nitric Oxide and Oxygen Tension in Bronchopulmonary Dysplasia, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.9, pp.1006-1019, 2004. ,
DOI : 10.1164/rccm.200310-1483OC
Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure, New England Journal of Medicine, vol.355, issue.4, pp.354-64, 2006. ,
DOI : 10.1056/NEJMoa060442
Pulmonary hypertension in bronchopulmonary dysplasia, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.40, issue.1, pp.240-246, 2014. ,
DOI : 10.1002/bdra.23241
Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?, Journal of Perinatology, vol.8, issue.1, pp.64-73, 2012. ,
DOI : 10.2459/JCM.0b013e328332e745
Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease, Circulation, vol.108, issue.90101, pp.167-73, 2003. ,
DOI : 10.1161/01.cir.0000087384.76615.60
Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery, Intensive Care Medicine, vol.29, issue.11, pp.1996-2003, 2003. ,
DOI : 10.1007/s00134-003-2016-4
Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption, Cardiol Young, 2006. ,
Use of Sildenafil to Facilitate Weaning From Inhaled Nitric Oxide in Children With Pulmonary Hypertension Following Surgery for Congenital Heart Disease, Journal of Intensive Care Medicine, vol.29, issue.11, pp.329-363, 2008. ,
DOI : 10.1177/0885066608321389
Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study, PEDIATRICS, vol.117, issue.4, 2006. ,
DOI : 10.1542/peds.2005-0523
Sildenafil in the treatment of pulmonary hypertension]. An Pediatría Barc Spain, pp.110-113, 2003. ,
Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. Intensive Care Med, pp.502-511, 2011. ,
A randomized, doubleblind , placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation, pp.324-358, 2012. ,
Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn, Pediatric Pulmonology, vol.154, issue.12, 2014. ,
DOI : 10.1002/ppul.22985
Cerebral hemorrhage associated with sildenafil (Revatio) in an infant. Pediatr Cardiol, pp.998-1007, 2009. ,
Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children???, European Journal of Cardio-Thoracic Surgery, vol.38, issue.1, pp.71-78, 2010. ,
DOI : 10.1016/j.ejcts.2010.01.045
Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports, Journal of Medical Case Reports, vol.100, issue.Suppl 1, p.171, 2014. ,
DOI : 10.1016/j.ijcard.2004.09.002
Evolving Management of Pediatric Pulmonary Arterial Hypertension: Impact of Phosphodiesterase Inhibitors, Pediatric Cardiology, vol.48, issue.Suppl 1, pp.213-222, 2013. ,
DOI : 10.1007/s00246-012-0598-8
Pulmonary Arterial Hypertension in Infants with Chronic Lung Disease: Will We Ever Understand It?, The Journal of Pediatrics, vol.157, issue.2, pp.186-90, 2010. ,
DOI : 10.1016/j.jpeds.2010.03.022
Beyond Pulmonary Hypertension: Sildenafil for Chronic Lung Disease of Prematurity, American Journal of Respiratory Cell and Molecular Biology, vol.48, issue.2, p.iii ? v, 2013. ,
DOI : 10.1165/rcmb.2012-0441ED
Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia, International Journal of Pediatrics, vol.77, issue.3, p.598606, 2012. ,
DOI : 10.1164/rccm.201101-0055OC